Open AccessPyloric stenosis associated Crohn's disease responding to adalimumab therapy
Author(s) -
Sameer Gaggar,
John Scott,
NP Thompson
Publication year - 2012
Publication title -
world journal of gastrointestinal pharmacology and therapeutics
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2150-5349
DOI - 10.4292/wjgpt.v3.i6.97
Subject(s) - medicine , adalimumab , crohn's disease , medical therapy , necrosis , disease , stenosis , infliximab , tumor necrosis factor alpha , pyloric stenosis , gastroenterology , surgery
Gastroduodenal Crohn's disease (CD) is rare and the response to standard medical therapy is often poor. Anti-tumor necrosis factor therapy has revolutionised the treatment of CD. We present a patient with pyloric stenosis associated with CD which improved with Adalimumab therapy. We recommend considering anti-tumor necrosis factor therapy in symptomatic gastroduodenal CD.